End-of-day quote
Shanghai S.E.
18:00:00 2024-06-27 EDT
|
5-day change
|
1st Jan Change
|
11.75
CNY
|
-.--%
|
|
-0.68%
|
+55.63%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
6,528
|
3,988
|
3,334
|
3,732
|
5,833
|
-
|
Enterprise Value (EV)
1 |
6,528
|
3,988
|
3,334
|
3,732
|
5,833
|
5,833
|
P/E ratio
|
21.3
x
|
18
x
|
13.2
x
|
11.4
x
|
13.9
x
|
12.2
x
|
Yield
|
1.72%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
7.49
x
|
-
|
-
|
-
|
4.52
x
|
3.87
x
|
EV / Revenue
|
7.49
x
|
-
|
-
|
-
|
4.52
x
|
3.87
x
|
EV / EBITDA
|
16.5
x
|
-
|
-
|
-
|
12.5
x
|
11
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
6.32
x
|
-
|
-
|
-
|
1.89
x
|
1.56
x
|
Nbr of stocks (in thousands)
|
512,239
|
512,239
|
501,172
|
494,294
|
494,294
|
-
|
Reference price
2 |
12.74
|
7.786
|
6.653
|
7.550
|
11.75
|
11.75
|
Announcement Date
|
20-03-19
|
21-03-30
|
22-04-25
|
24-04-25
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
871.9
|
-
|
-
|
-
|
1,291
|
1,508
|
EBITDA
1 |
394.5
|
-
|
-
|
-
|
466
|
529
|
EBIT
1 |
367.5
|
-
|
-
|
-
|
491
|
563
|
Operating Margin
|
42.15%
|
-
|
-
|
-
|
38.03%
|
37.33%
|
Earnings before Tax (EBT)
1 |
367.4
|
-
|
-
|
-
|
491
|
563
|
Net income
1 |
306.8
|
221.8
|
250.5
|
328.4
|
424
|
486
|
Net margin
|
35.19%
|
-
|
-
|
-
|
32.84%
|
32.23%
|
EPS
2 |
0.5977
|
0.4337
|
0.5051
|
0.6643
|
0.8429
|
0.9643
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
0.2187
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-03-19
|
21-03-30
|
22-04-25
|
24-04-25
|
-
|
-
|
Fiscal Period: December |
2022 S1
|
2022 Q3
|
---|
Net sales
1 |
-
|
343.6
|
EBITDA
|
-
|
-
|
EBIT
|
-
|
-
|
Operating Margin
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
|
227.6
|
-
|
Net margin
|
-
|
-
|
EPS
2 |
0.4643
|
0.2194
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
22-08-15
|
22-10-28
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
33.5%
|
-
|
-
|
-
|
18.8%
|
17.8%
|
ROA (Net income/ Total Assets)
|
29.4%
|
-
|
-
|
-
|
16.7%
|
15.9%
|
Assets
1 |
1,043
|
-
|
-
|
-
|
2,539
|
3,057
|
Book Value Per Share
2 |
2.020
|
-
|
-
|
-
|
6.210
|
7.540
|
Cash Flow per Share
2 |
0.4700
|
-
|
-
|
-
|
1.050
|
1.220
|
Capex
|
62.9
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
7.21%
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-03-19
|
21-03-30
|
22-04-25
|
24-04-25
|
-
|
-
|
Last Close Price
11.75
CNY Average target price
12.64
CNY Spread / Average Target +7.60% Consensus |
1st Jan change
|
Capi.
|
---|
| +55.63% | 799M | | +2.01% | 99.64B | | -11.38% | 59.01B | | +73.33% | 48.81B | | +5.26% | 34.94B | | -0.27% | 31.15B | | +2.59% | 18.62B | | +17.33% | 17.44B | | +5.92% | 13.51B | | -5.51% | 12.73B |
Other Commodity Chemicals
|